McClarren Financial Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-58
Closed 313
2021
Q2
$0 Buy
+58
New ﹤0.01% 327